4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-18-028123
Options or other derivatives
- Chief Medical Officer acquired 64,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kwon Paul · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-05-03 | Grant or award : show line 1 in the form Stock Option | +64,000 | $8.49 | 2028-05-02 | 64,000 | 252,512 | D |
Loading xslF345X03/doc4.xml…